Peptide-Based Matrices as Drug Delivery Vehicles

被引:24
作者
Ezzat, Kariem [1 ]
El Andaloussi, Samir [1 ]
Abdo, Rania [1 ]
Langel, Ulo [1 ]
机构
[1] Stockholm Univ, Dept Neurochem, Arrhenius Labs Nat Sci, SE-10691 Stockholm, Sweden
关键词
Cell penetrating peptide; protein transduction domain; delivery; siRNA; splice correction; Poly-L-lysine; antimicrobial peptides; CELL-PENETRATING PEPTIDES; ARGININE-RICH PEPTIDES; ANTISENSE MORPHOLINO OLIGOMERS; ANTENNAPEDIA HOMEOBOX PEPTIDE; EFFICIENT SPLICING CORRECTION; HUMAN IMMUNODEFICIENCY VIRUS; VECTOR-MEDIATED STRATEGY; SINGLE-CHAIN ANTIBODIES; PLURIPOTENT STEM-CELLS; ISCHEMIC BRAIN-INJURY;
D O I
10.2174/138161210790963832
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Peptides, polypeptides, and proteins have been extensively studied for their various structural and functional roles in living organisms. However, breakthrough discoveries in the last decades identified some peptide-based matrices that posses the ability to traverse biological membranes, and many peptides, polypeptides and even complete proteins have been shown to have such properties. Hence, these matrices have been successfully used for the intracellular delivery of many therapeutic cargos including small molecules, proteins, peptides, oligonucleutides, plasmids and nanoparticles both in vitro and in vivo. Being neither toxic nor carcinogenic and meanwhile efficient in delivery, they are recognized as very promising vectors to overcome the shortcomings of the available technologies. The characteristics of these peptide-based matrices and their applications in drug delivery are here briefly illustrated together with current challenges and future prospects.
引用
收藏
页码:1167 / 1178
页数:12
相关论文
共 141 条
[1]   Efficient splicing correction by PNA conjugation to an R6-Penetratin delivery peptide [J].
Abes, Said ;
Turner, John J. ;
Ivanova, Gabriela D. ;
Owen, David ;
Williams, Donna ;
Arzumanov, Andrey ;
Clair, Philippe ;
Gait, Michael J. ;
Lebleu, Bernard .
NUCLEIC ACIDS RESEARCH, 2007, 35 (13) :4495-4502
[2]   Vectorization of morpholino oligomers by the (R-Ahx-R)4 peptide allows efficient splicing correction in the absence of endosomolytic agents [J].
Abes, Said ;
Moulton, Hong M. ;
Clair, Philippe ;
Prevot, Paul ;
Youngblood, Derek S. ;
Wu, Rebecca P. ;
Iversen, Patrick L. ;
Lebleu, Bernard .
JOURNAL OF CONTROLLED RELEASE, 2006, 116 (03) :304-313
[3]   DOWN-REGULATION OF AMYLOID PRECURSOR PROTEIN INHIBITS NEURITE OUTGROWTH IN-VITRO [J].
ALLINQUANT, B ;
HANTRAYE, P ;
MAILLEUX, P ;
MOYA, K ;
BOUILLOT, C ;
PROCHIANTZ, A .
JOURNAL OF CELL BIOLOGY, 1995, 128 (05) :919-927
[4]   Maurocalcine as a Non Toxic Drug Carrier Overcomes Doxorubicin Resistance in the Cancer Cell Line MDA-MB 231 [J].
Aroui, Sonia ;
Ram, Narendra ;
Appaix, Florence ;
Ronjat, Michel ;
Kenani, Abderraouf ;
Pirollet, Fabienne ;
De Waard, Michel .
PHARMACEUTICAL RESEARCH, 2009, 26 (04) :836-845
[5]   Conjugates of antisense oligonucleotides with the Tat and antennapedia cell-penetrating peptides: Effects on cellular uptake, binding to target sequences, and biologic actions [J].
Astriab-Fisher, A ;
Sergueev, D ;
Fisher, M ;
Shaw, BR ;
Juliano, RL .
PHARMACEUTICAL RESEARCH, 2002, 19 (06) :744-754
[6]   Evaluation of cell-penetrating peptides (CPPs) as vehicles for intracellular delivery of antisense peptide nucleic acid (PNA) [J].
Bendifallah, Nadia ;
Rasmussen, Frank Winther ;
Zachar, Vladimir ;
Ebbesen, Peter ;
Nielsen, Peter E. ;
Koppelhus, Uffe .
BIOCONJUGATE CHEMISTRY, 2006, 17 (03) :750-758
[7]   REGULATION OF GENE-EXPRESSION WITH DOUBLE-STRANDED PHOSPHOROTHIOATE OLIGONUCLEOTIDES [J].
BIELINSKA, A ;
SHIVDASANI, RA ;
ZHANG, LQ ;
NABEL, GJ .
SCIENCE, 1990, 250 (4983) :997-1000
[8]  
Cao GD, 2002, J NEUROSCI, V22, P5423
[9]   Utilization of synthetic peptides containing nuclear localization signals for nonviral gene transfer systems [J].
Cartier, R ;
Reszka, R .
GENE THERAPY, 2002, 9 (03) :157-167
[10]   Basic research tries to decrease the risks of translational medicine [J].
Cavazzana-Calvo, M. .
GENE THERAPY, 2009, 16 (03) :309-310